⏳ Fetching live dividend data...
Home › Calculator › HZNP Dividend Calculator 2026
Horizon Therapeutics Public Limited Company · NASDAQ
Price: $116.30 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in HZNP → $10.42M in 10 years · $14.58/month
Horizon Therapeutics Public Limited Company operates as a biotechnology enterprise, primarily concentrating on the identification, refinement, and commercialization of pharmaceutical products designed to address significant medical needs for individuals afflicted by rare, autoimmune, and severe inflammatory conditions. The company's operations are divided into two principal divisions: Orphan and Inflammation. Its extensive product lineup features twelve distinct medications, targeting therapeutic areas such as rare diseases, gout, ophthalmic conditions, and various forms of inflammation. Among its marketed offerings are TEPEZZA (an intravenous infusion), KRYSTEXXA (also administered intravenously), the oral liquid RAVICTI, PROCYSBI (available as oral delayed-release capsules and granules), the subcutaneous injectable ACTIMMUNE, BUPHENYL (oral tablets and powder), the inhaled solution QUINSAIR, and the intravenous injection UPLIZNA. Furthermore, the company's portfolio includes PENNSAID (a topical solution), DUEXIS (oral tablets), RAYOS (delayed-release oral tablets), and VIMOVO (delayed-release oral tablets). Horizon Therapeutics maintains strategic partnerships with several entities, including HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; and Arrowhead Pharmaceuticals, Inc. Founded in 2005, the company, originally known as Horizon Pharma Public Limited Company, rebranded to its current name in May 2019. Its global headquarters are situated in Dublin, Ireland, complemented by additional offices located in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HZNP position with:
Real after-tax yield depends on where you live and how you hold HZNP.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.72% | -1.08% | $172 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.46% | -1.34% | $146 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.38% | -1.42% | $138 / yr |
| 🇬🇧 UK ISA | 0% | 1.72% | -1.08% | $172 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.57% | -1.23% | $157 / yr |
| 🇨🇦 TFSA | 0% | 1.72% | -1.08% | $172 / yr |
| 🇨🇦 CA Taxable | 25% | 1.29% | -1.51% | $129 / yr |
| 🇦🇺 Super (pension) | 15% | 1.46% | -1.34% | $146 / yr |
| 🇦🇺 AU Taxable | 30% | 1.20% | -1.60% | $120 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.27% | -1.53% | $127 / yr |
| 🇫🇷 FR Taxable | 30% | 1.20% | -1.60% | $120 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
HZNP pays quarterly — 4 times per year. Next ex-div: TBD.
How HZNP compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HZNP sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2023-10-06 | 23,092 | $15.23 | $351.7K | ||
| D-Return | 2023-10-06 | 31,153 | $15.12 | $471.0K | ||
| D-Return | 2023-10-06 | 4,016 | — | — | ||
| D-Return | 2023-10-06 | 8,548 | $28.53 | $243.9K | ||
| D-Return | 2023-10-06 | 10,000 | $116.50 | $1.17M | ||
| D-Return | 2023-10-06 | 10,838 | $13.87 | $150.3K | ||
| D-Return | 2023-10-06 | 4,016 | — | — | ||
| D-Return | 2023-10-06 | 9,306 | $116.50 | $1.08M | ||
| D-Return | 2023-10-06 | 52,232 | $12.19 | $636.7K | ||
| D-Return | 2023-10-06 | 4,016 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HZNP dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Horizon Therapeutics Public Limited Company (HZNP) is currently trading at $116.30, trading near its 52-week high. The current dividend yield is 1.72% based on an annual payout of $2.00 per share.
Horizon Therapeutics Public Limited Company (HZNP) is a healthcare stock currently trading at $116.30 with a dividend yield of 1.72%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →